Refeyn announces appointment of Fiona Coats as Chief Marketing Officer

FHS
May 22, 2024
3:47 pm

Refeyn, the company behind pioneering mass photometry technologies, is delighted to announce the appointment of Fiona Coats as Chief Marketing Officer, effective from June, 2024.

FDA sets June decision deadline for potential full approval, label expansion of Sarepta’s Duchenne gene therapy

Sarepta Therapeutics could soon notch another regulatory win. Despite the company and its Duchenne gene therapy getting dogged by debate, and then a failed confirmatory

February 17, 2024

Four genes found to significantly influence menopause timing and cancer risk

New research has found four genes with some of the largest known effects on the timing of menopause discovered to date, providing new insight into

September 11, 2024

The Folly of Trying to Map Out the Appeals Process for Insurance Denials

Health insurers reject millions of claims for treatment every year in America. Corporate insiders, recordings, and internal emails expose the system and its harm. Have

September 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.